Axena Health Named Finalist for the Digital Health Hub Foundation - Digital Health & AI Awards 2026 at HLTH

Finalist recognition in the Best in Class track highlights the company's work to redefine the standard of care for women's pelvic health

NEWTON, Mass., October 20, 2026--Axena Health, Inc. (Axena Health), a women's health company redefining the standard of care for pelvic health conditions through clinically proven, non-invasive treatments, today announced it has been named a finalist for the Digital Health Hub Foundation – Digital Health & AI Awards 2026 at HLTH. Selected from a pool of more than 1,300 participating companies across all tracks and categories, Axena Health is recognized in the Best in Class Track for Women's and Family Health.

"Too many women plan their days around bladder or bowel leakage without knowing that effective, non-invasive treatment is available," said Samantha Pulliam, MD, FACOG, CEO and Chief Medical Officer of Axena Health. "Axena Health's goal is to change that by expanding access to clinically proven pelvic health treatment that fits into women's everyday lives. This recognition as a finalist affirms our team's efforts to close longstanding gaps in care and advance the mission that drives everything we do: redefining the standard of care for women's pelvic health."

Now in its eighth year, the Digital Health Hub Awards celebrate organizations that demonstrate excellence in leveraging digital advancements to enhance healthcare services and patient outcomes. Axena Health was selected as a finalist from a pool of more than 1,300 submissions across all tracks and categories.

"The transition from Quarterfinalist to Finalist is where the competition really gets exciting," said Mark H. Goldstein, Chairman of the Digital Health Hub Foundation. "We're seeing companies move beyond promising ideas to solutions that are changing how healthcare is delivered, experienced, and accessed. Our finalists represent an extraordinary range of innovation, and we can't wait to bring their achievements to the stage at HLTH in November."

Representatives from Axena Health will attend HLTH USA in November to connect with healthcare leaders, clinicians and industry innovators and discuss how digital health technologies can help expand access to evidence-based treatment for pelvic floor disorders.

Axena Health is working to expand access to effective, evidence-based treatment for urinary and chronic fecal incontinence through its flagship product, the Leva® Pelvic Health System. The clinician-prescribed program combines FDA-cleared technology with personalized coaching, educational resources and progress tracking to bring supervised pelvic floor muscle training into women's homes.